Madrigal Pharmaceuticals (NASDAQ:MDGL) Director Paul Friedman Sells 24,520 Shares
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) Director Paul Friedman sold 24,520 shares of the business’s stock in a transaction dated Friday, January 9th. The stock was sold at an average price of $522.39, for a total value of $12,809,002.80. Following the transaction, the director directly owned 187,164 shares of the company’s stock, valued […]
13 Jan 17:18 · The Cerbat Gem